Kim P. Schellekens, MD (she/her/hers)

PhD Candidate
Princess Máxima Center for Pediatric Oncology and Erasmus MC, Netherlands

Kim Schellekens is a Medical Doctor and PhD student in the group of Prof. dr. C.M. Zwaan at the Princess Máxima Center for Pediatric Oncology in Utrecht, the Netherlands, and the Erasmus Medical Center in Rotterdam, the Netherlands. Her research focuses on clinical studies with ALK inhibitors and anti-emetic prophylaxis in pediatric oncology.

Poster(s):

• (P 558) TRIAL IN PROGRESS: A PHASE 1/2 STUDY OF BRIGATINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH ALK POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA OR INFLAMMATORY MYOFIBROBLASTIC TUMORS (ITCC-098)